• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Portfolio management

Wise’s Biolchim bolts on Ilsa

  • Amedeo Goria
  • Amedeo Goria
  • 07 March 2017
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Private-equity-backed Biolchim Group has acquired a 60% stake in Ilsa, an Italian fertiliser manufacturer.

According to a statement, the company supported the acquisition through capital from its own balance sheet and a credit facility provided by Unicredit.

Following the acquisition, the merged group expects to generate an aggregate turnover of €115m in 2017 and will manage eight production plants with 300 employees. Moreover, according to a statement, the group will be able to manufacture the main raw materials required for bio-stimulant products.

Ilsa

  • DEAL:

    Portfolio management

  • LOCATION:

    Arzignano

  • SECTOR:

    Speciality chemicals

  • FOUNDED:

    1956

  • TURNOVER:

    €22m

  • EBITDA:

    €3m

Prior to the acquisition, Biolchim posted €85m in revenues with EBITDA of €16.5m.

Previous funding
In April 2006, Fondo Centro Impresa, the private equity fund managed by Sanpaolo IMI Private Equity, fully acquired the business, along with the management team and a group of private investors.

As part of the deal, Fondo Centro Impresa invested €3.5m for a 45% shareholding, while other financial investors acquired 49%. The management team took the remaining 6%.

More recently, Assietta Private Equity acquired a 27% stake in the business from the founders via its vehicle Fondo Dimensione Impresa in June 2010.

Lastly, in January 2013, Wise backed Biolchim's MBO via its vehicle Wisequity III for approximately €21m. The transaction resulted in the exit of Sanpaolo IMI and Assietta.

Following the transaction, the company acquired Italian home and garden products manufacturer Cifo in August 2014, Canadian algae extracts producer West Coast Marine Bio Processing in February 2015 and Hungarian substrate and compost manufacturer Matécsa in January 2017.

Company
Ilsa is headquartered in Arzignano, near Vicenza, and produces organic and organic-mineral fertilisers and bio-stimulants. Established in 1956, the company has two production plants in Italy and one in Brazil. It generated a turnover of €22m with EBITDA of €3m in 2016.

People
Biolchim Group – Leonardo Valenti (CEO).
Ilsa – Paolo Girelli (chair).

Advisers
Acquirer – Studio Spada & Partners (tax); Simmons & Simmons (debt advisory); LabAnalysis (environmental due diligence); LTA Alliance (legal).
Vendor – Arkios (corporate finance); Gitti and Partners (legal).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Portfolio management
  • Industrials
  • Southern Europe
  • Italy
  • Wise SGR
  • Build-up

More on Portfolio management

An office building with a cloudy sky in the background
PlusServer owner BC Partners seeks sale via Jefferies as loan maturity looms

GP acquired the German cloud solutions group in 2017 via BC European Capital X

  • Exits
  • 15 August 2023
Runners passing the baton
Volpi raises EUR 250m continuation vehicle for 2016-vintage assets

Volpi Capital Investments Conti will hold Dutch geospatial data company Cyclomedia and UK-based surveillance group Digital Barriers

  • Secondaries
  • 28 June 2023
Bolt-ons and buy-and-build platforms
The Bolt-Ons Digest – 17 April 2023

Unquote’s selection of the latest add-ons with Triton's BFC Group, Seven2's Groupe Crystal, Palatine's FourNet and more

  • Expansion
  • 17 April 2023
Boardroom discussions and office openings
MJ Hudson business divisions acquired by Apex Group

Sale follows suspension of listed UK-headquartered asset management service provider’s shares in December 2022

  • Advisory
  • 11 April 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013